ClinicaliQ Trial Snapshot
- Longitudinal Population-based Observational Study of COVID-19 in the UK Population — Recruiting • Respiratory / COPD / Asthma • NCT04330599.
- What is being tested: COVIDENCE UK is an observational longitudinal study investigating risk factors for COVID-19 infection and adverse outcomes, whilst characterising the disease's natural history and long-term health impacts across the UK population.
- Patient eligibility overview: This is a population-based study recruiting from the general UK population; participants are followed longitudinally to capture incident COVID-19 cases and their subsequent clinical trajectories without intervention.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
COVIDENCE UK is a population-based observational longitudinal study that has the following objectives: 1. To determine risk factors for incident COVID-19 and for adverse outcomes of COVID-19 in the UK population 2. To characterise the natural history of COVID-19 in the UK population 3. To evaluate the impact of COVID-19 on the physical and mental health of the UK population 4. To provide a resource from which to identify potential participants for future clinical trials, and to use data collected in COVIDENCE as comparison or control data for trial participants…
Eligibility Snapshot
- : * UK resident * Age ≥16 years
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.